TRIMBOW is a combination of beclomethasone dipropionate (BDP) (an inhaled corticosteroid [ICS]), formoterol fumarate (FF) (a long-acting beta₂-adrenergic agonist [LABA]), and glycopyrrolate (G) (an anticholinergic) indicated for the maintenance treatment of asthma in adult patients aged 18 years and older.

Limitations of Use:

• Not indicated for relief of acute bronchospasm.